🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Regulatory Affairs

B2B Scaling Roundtable: Fieldfisher to Host Dublin Tech Founders on July 1st

Sreepriya Prasannan
Sreepriya Prasannan
Speed:
B2B Scaling Roundtable: Fieldfisher to Host Dublin Tech Founders on July 1st

Prominent international law firm Fieldfisher has announced a private B2B Scaling Roundtable scheduled for July 1st, 2026, at Kennedy’s Pub in Dublin 2. The event targets founders, venture-backed operators, and sales directors currently scaling business-to-business enterprises.

The event is designed to blend practical sales leadership strategies with a deep dive into the corporate legal traps that frequently catch fast-growing tech companies.

Commercial Strategy and Legal Pitfalls

The roundtable agenda features a diverse panel of corporate and growth leaders:

  • Sales Panel: A panel of active B2B sales directors sharing lessons on scaling sales pipelines, expanding into North America, and moving upmarket into enterprise contracts.
  • Keynote: Former Leinster and Ireland rugby player Fergus McFadden will deliver a keynote address sharing lessons on high-performance teamwork, leadership under pressure, and building resilient cultures.
  • Legal Briefing: Fieldfisher Partner Jamie Woodcock will present a legal compliance brief detailing the common pitfalls that catch scaling SaaS companies, focusing on intellectual property security and international commercial contracts.

Waitlist Registration

The event is currently at maximum capacity due to high demand among regional tech founders. However, operators looking to attend can join the waitlist via the Fieldfisher Dublin event portal to secure tickets in the event of cancellations.

Key Legal and Operational Scaling Challenges

The Fieldfisher B2B Scaling Roundtable brings together Dublin's tech founders to address the complex legal landscapes of international expansion. As companies scale from Ireland into the US or mainland Europe, they face significant regulatory hurdles, including GDPR alignment, cross-border intellectual property (IP) structuring, and international tax compliance.

Fieldfisher's corporate legal team will lead discussions on venture capital readiness, detailing how founders can structure their governance models, cap tables, and employee share option schemes (ESOPs) to attract Tier-1 international investors while safeguarding the company's core IP assets.

Frequently Asked Questions

Who is hosting the B2B Scaling Roundtable?

The event is hosted by Fieldfisher, a leading European law firm, at their Dublin office, designed specifically for technology founders and scaling SaaS executives.

What are the primary topics discussed at the roundtable?

The roundtable focuses on cross-border IP structuring, GDPR compliance during international expansion, and preparing cap tables and corporate governance for venture capital funding rounds.

How can founders register for the Fieldfisher event?

Founders can request an invitation through Fieldfisher's Dublin corporate technology department or register via the links on the Innovate Dublin events portal.

Legal Frameworks for Venture Capital and ESOP Structuring

During the roundtable, Fieldfisher's corporate technology partners will walk founders through the mechanics of preparing a startup for institutional investment. When negotiating a Term Sheet with international venture capitalists, founders must be prepared for rigorous due diligence. The discussion will cover common cap table pitfalls, such as having too many early-stage non-active shareholders or poorly structured advisor options, which can act as red flags for Series A investors.

A key focus will be on the design of Employee Share Option Schemes (ESOPs). In Ireland, the Key Employee Engagement Programme (KEEP) provides tax-efficient share options for SMEs, but navigating its strict eligibility rules requires careful legal structuring. Fieldfisher will share case studies on how to balance KEEP options with standard share schemes to attract global executive talent while remaining compliant with Irish tax legislation.

Intellectual Property (IP) Protection in Cross-Border Scaling

For B2B software companies, intellectual property is their most valuable asset. Scaling into foreign markets, particularly the US, increases the risk of IP litigation and copying. The roundtable will address how to establish robust IP assignment agreements with all employees and contractors, and how to structure a patent or copyright portfolio to withstand international scrutiny. Fieldfisher will also highlight the importance of secure data processing agreements (DPAs) when transferring customer data across borders under GDPR rules.

Legal Frameworks for Venture Capital and ESOP Structuring

During the roundtable, Fieldfisher's corporate technology partners will walk founders through the mechanics of preparing a startup for institutional investment. When negotiating a Term Sheet with international venture capitalists, founders must be prepared for rigorous due diligence. The discussion will cover common cap table pitfalls, such as having too many early-stage non-active shareholders or poorly structured advisor options, which can act as red flags for Series A investors.

A key focus will be on the design of Employee Share Option Schemes (ESOPs). In Ireland, the Key Employee Engagement Programme (KEEP) provides tax-efficient share options for SMEs, but navigating its strict eligibility rules requires careful legal structuring. Fieldfisher will share case studies on how to balance KEEP options with standard share schemes to attract global executive talent while remaining compliant with Irish tax legislation.

Intellectual Property (IP) Protection in Cross-Border Scaling

For B2B software companies, intellectual property is their most valuable asset. Scaling into foreign markets, particularly the US, increases the risk of IP litigation and copying. The roundtable will address how to establish robust IP assignment agreements with all employees and contractors, and how to structure a patent or copyright portfolio to withstand international scrutiny. Fieldfisher will also highlight the importance of secure data processing agreements (DPAs) when transferring customer data across borders under GDPR rules.

Reviewed for editorial accuracy by Sreepriya Prasannan, Founder & Editor MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany
Our standards
Drugs in this article: current clinical trials
Most-trialled drugs in our registers
Browse all trial registers →

Get the Friday brief

One email every Friday: the week's Irish pharma news, new EMA and FDA approvals, EU and US medicine shortages and how many trials are recruiting in Ireland, built from public registers.

Free. Unsubscribe from any email with one click. See our privacy policy.

About the Author
Sreepriya Prasannan

Sreepriya Prasannan

Writer at Priya Life Science · Regulatory Affairs

Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.

Discussion
No comments yet. Be the first to share your thoughts!
Leave a Comment